Recordati Rare Diseases Inc., the makers of CYSTADROPS, launched a website to support the launch of the eye treatment...
read moreIn a statement from Leadient Biosciences on October 9th, the company announced an availability shortage may impact cystinosis patients...
read moreBeginning September 15, 2020, Recordati Rare Diseases announced the availability of CYSTADROPS across the United States. CYSTADROPS are a...
read moreTo address the shortage of Cystaran eye drops some members of our community may have encountered recently, Leadient Biosciences...
read moreRecordati announced approval of an eye drop treatment to reduce corneal crystals. “We are pleased to bring Cystadrops® to...
read moreJoin the first video conference session created by the Adult Leadership Advisory Board - Saturday, March 21 at 4pm...
read moreHealth Canada approved the first cysteamine eye drop solution to help people living with cystinosis. Read more…
read more